Skip to main content


Europe, the United States and Latin American are the markets where the Institut Guttmann and Indra are marketing an innovative new system that allows them to provide clinical neurorehabilitation services to treat acquired brain injury, dementia, schizophrenia and childhood development disorders.

Registered under the brand Guttmann NeuroPersonalTrainer®, this system uses the latest discoveries in cognitive neuroscience and the most advanced ICT and artificial intelligence solutions, with systems like KDD (knowledge data discovery) and data mining, allowing them to automatically adapt the system to the needs of each patient in real time.

The great value added of this system is its personalized, monitored service, which generates knowledge, and its affordable and sustainable costs for the various social players involved.

The Guttmann NeuroPersonalTrainer® is the result of a research project that began in 2003 under the name Previrnec, carried out by the Guttmann Institute, the University of Rovira i Virgili and the Barcelona Biomedical Engineering Research Center of the Universitat Politècnica de Catalunya. This morning, the system was officially presented, with Secretary General for Health Roser Fernández, who highlighted that “projects like this one illustrate the great potential of healthcare and the existing productive fabric associated with this field.”

So far, the system has treated more than 800 patients using over 20 platforms installed at the Guttmann Institute and other healthcare centers, and more than 100 patients have received clinical care in their home. In total, some 32,000 sessions have been carried out with more than 210,000 tasks, and results show that 80% of patients improve significantly in terms of attention, memory and executive functions.

This model, which has demonstrated its clinical efficacy, is an efficient solution for both public and private healthcare systems, whether through neurorehabilitation services in general or county hospitals, social day-patient hospitals, day centers and assisted living facilities or in the patient’s own home. 

Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.